Click here to get full coverage on Permira looks to launch $4B sale of CDMO Cambrex: FT - Fierce Pharma

Permira looks to launch $4B sale of CDMO Cambrex: FT  Fierce Pharma

Permira looks to launch $4B sale of CDMO Cambrex: FT - Fierce Pharma

Click here to get full coverage on Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium - Korea JoongAng Daily

Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium  Korea JoongAng Daily

Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium - Korea JoongAng Daily

Click here to get full coverage on Matica Biotechnology inks AAV vector CDMO deal with Cirsium Biosciences - koreabiomed.com

Matica Biotechnology inks AAV vector CDMO deal with Cirsium Biosciences  koreabiomed.com

Matica Biotechnology inks AAV vector CDMO deal with Cirsium Biosciences - koreabiomed.com

Click here to get full coverage on Samsung Biologics wins $1.3 bn US order, its second-largest ever - KED Global

Samsung Biologics wins $1.3 bn US order, its second-largest ever  KED Global

Samsung Biologics wins $1.3 bn US order, its second-largest ever - KED Global

Click here to get full coverage on Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer - Endpoints News

Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer  Endpoints News

Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer - Endpoints News

Click here to get full coverage on Vaccine CDMO Market Size to Hit USD 11.16 Billion by 2034 - Precedence Research

Vaccine CDMO Market Size to Hit USD 11.16 Billion by 2034  Precedence Research

Vaccine CDMO Market Size to Hit USD 11.16 Billion by 2034 - Precedence Research

Click here to get full coverage on Samsung Bio inks US contract manufacturing deal worth $1.3B - Fierce Pharma

Samsung Bio inks US contract manufacturing deal worth $1.3B  Fierce Pharma

Samsung Bio inks US contract manufacturing deal worth $1.3B - Fierce Pharma

Click here to get full coverage on BioFactura Launches Capitol Biologics - New CDMO Division to Accelerate Biologics Development from Concept to Clinic - Yahoo Finance

BioFactura Launches Capitol Biologics - New CDMO Division to Accelerate Biologics Development from Concept to Clinic  Yahoo Finance

BioFactura Launches Capitol Biologics - New CDMO Division to Accelerate Biologics Development from Concept to Clinic - Yahoo Finance

Click here to get full coverage on Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - PR Newswire

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet  PR Newswire

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - PR Newswire

Click here to get full coverage on Cosmetic CDMO Market Research Report 2025 - InsightAce Analytic

Cosmetic CDMO Market Research Report 2025  InsightAce Analytic

Cosmetic CDMO Market Research Report 2025 - InsightAce Analytic

Click here to get full coverage on J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub - Pharmaceutical Technology

J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub  Pharmaceutical Technology

J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub - Pharmaceutical Technology

Click here to get full coverage on Oncology CDMO Market Size, Report By 2034 - Precedence Research

Oncology CDMO Market Size, Report By 2034  Precedence Research

Oncology CDMO Market Size, Report By 2034 - Precedence Research

Click here to get full coverage on Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities - PR Newswire

Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities  PR Newswire

Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities - PR Newswire

Click here to get full coverage on CDMO insights podcast series: Our Experience is Your Strength | Episode #5 Sustainable packaging - Pharmaceutical Technology

CDMO insights podcast series: Our Experience is Your Strength | Episode #5 Sustainable packaging  Pharmaceutical Technology

CDMO insights podcast series: Our Experience is Your Strength | Episode #5 Sustainable packaging - Pharmaceutical Technology

Click here to get full coverage on U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica - Yahoo Finance

U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica  Yahoo Finance

U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica - Yahoo Finance

Click here to get full coverage on CDMO OXB raises £60M to support US expansion ambitions - Fierce Pharma

CDMO OXB raises £60M to support US expansion ambitions  Fierce Pharma

CDMO OXB raises £60M to support US expansion ambitions - Fierce Pharma

Click here to get full coverage on High-Potency API (HPAPI) CDMO Market Size, Report by 2034 - Precedence Research

High-Potency API (HPAPI) CDMO Market Size, Report by 2034  Precedence Research

High-Potency API (HPAPI) CDMO Market Size, Report by 2034 - Precedence Research

Click here to get full coverage on CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma

CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling  Fierce Pharma

CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma

Click here to get full coverage on Hormonal Drug CDMO Market Size, Report by 2034 - Precedence Research

Hormonal Drug CDMO Market Size, Report by 2034  Precedence Research

Hormonal Drug CDMO Market Size, Report by 2034 - Precedence Research

Click here to get full coverage on Nucleic acid CDMO TriLink lays off 90 in California as parent Maravai restructures - Fierce Pharma

Nucleic acid CDMO TriLink lays off 90 in California as parent Maravai restructures  Fierce Pharma

Nucleic acid CDMO TriLink lays off 90 in California as parent Maravai restructures - Fierce Pharma

Click here to get full coverage on Tufts study: Integrated CRO-CDMO contractors offer financial benefits - BioXconomy

Tufts study: Integrated CRO-CDMO contractors offer financial benefits  BioXconomy

Tufts study: Integrated CRO-CDMO contractors offer financial benefits - BioXconomy

Click here to get full coverage on After M&A plays, CDMO Sanner cements North American presence with 1st US plant - Fierce Pharma

After M&A plays, CDMO Sanner cements North American presence with 1st US plant  Fierce Pharma

After M&A plays, CDMO Sanner cements North American presence with 1st US plant - Fierce Pharma

Click here to get full coverage on The CDMO Surge: Why Pharma Is Outsourcing More Than Ever - News-Medical

The CDMO Surge: Why Pharma Is Outsourcing More Than Ever  News-Medical

The CDMO Surge: Why Pharma Is Outsourcing More Than Ever - News-Medical

Click here to get full coverage on ESTEVE CDMO Acquires Regis Technologies, expanding U.S. presence and capabilities - PR Newswire

ESTEVE CDMO Acquires Regis Technologies, expanding U.S. presence and capabilities  PR Newswire

ESTEVE CDMO Acquires Regis Technologies, expanding U.S. presence and capabilities - PR Newswire

Click here to get full coverage on PCI, on CDMO growth journey, nets 'sizable' investment from private equity heavyweights - Fierce Pharma

PCI, on CDMO growth journey, nets 'sizable' investment from private equity heavyweights  Fierce Pharma

PCI, on CDMO growth journey, nets 'sizable' investment from private equity heavyweights - Fierce Pharma

Click here to get full coverage on CDMO Market Hits USD 161 Billion in 2023, Set to Double by 2033 - Market.us Media

CDMO Market Hits USD 161 Billion in 2023, Set to Double by 2033  Market.us Media

CDMO Market Hits USD 161 Billion in 2023, Set to Double by 2033 - Market.us Media

Click here to get full coverage on CDMO BioSpring beefs up nucleic acid production with new API plant - Fierce Pharma

CDMO BioSpring beefs up nucleic acid production with new API plant  Fierce Pharma

CDMO BioSpring beefs up nucleic acid production with new API plant - Fierce Pharma

Click here to get full coverage on National Resilience will close 6 of its 10 plants and carry on as streamlined CDMO - Fierce Pharma

National Resilience will close 6 of its 10 plants and carry on as streamlined CDMO  Fierce Pharma

National Resilience will close 6 of its 10 plants and carry on as streamlined CDMO - Fierce Pharma

Click here to get full coverage on Cell and Gene Therapy CDMO Market Size to Hit USD 74.03 Billion by 2034 - Precedence Research

Cell and Gene Therapy CDMO Market Size to Hit USD 74.03 Billion by 2034  Precedence Research

Cell and Gene Therapy CDMO Market Size to Hit USD 74.03 Billion by 2034 - Precedence Research

Click here to get full coverage on CDMO Samsung Biologics telegraphs spinoff of biosim unit - Fierce Pharma

CDMO Samsung Biologics telegraphs spinoff of biosim unit  Fierce Pharma

CDMO Samsung Biologics telegraphs spinoff of biosim unit - Fierce Pharma

Click here to get full coverage on Expert tips to choose the right CDMO for your biotech company - Labiotech.eu

Expert tips to choose the right CDMO for your biotech company  Labiotech.eu

Expert tips to choose the right CDMO for your biotech company - Labiotech.eu

Click here to get full coverage on 172% Revenue Surge: Scinai's CDMO Business Powers Growth as Biotech Secures $4.2M and Expands Pipeline - Stock Titan

172% Revenue Surge: Scinai's CDMO Business Powers Growth as Biotech Secures $4.2M and Expands Pipeline  Stock Titan

172% Revenue Surge: Scinai's CDMO Business Powers Growth as Biotech Secures $4.2M and Expands Pipeline - Stock Titan

Click here to get full coverage on CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing? - DCAT Value Chain Insights

CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing?  DCAT Value Chain Insights

CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing? - DCAT Value Chain Insights

Click here to get full coverage on Resilience Provides Customers With Update on CDMO Business Strategy and Manufacturing Footprint - Yahoo Finance

Resilience Provides Customers With Update on CDMO Business Strategy and Manufacturing Footprint  Yahoo Finance

Resilience Provides Customers With Update on CDMO Business Strategy and Manufacturing Footprint - Yahoo Finance

Click here to get full coverage on Charles River addresses rough conditions in cell therapy CDMO business - BioProcess International

Charles River addresses rough conditions in cell therapy CDMO business  BioProcess International

Charles River addresses rough conditions in cell therapy CDMO business - BioProcess International

Click here to get full coverage on Major MedTech Expansion: Quasar Medical Acquires Two Strategic Facilities to Create Global CDMO Powerhouse - Stock Titan

Major MedTech Expansion: Quasar Medical Acquires Two Strategic Facilities to Create Global CDMO Powerhouse  Stock Titan

Major MedTech Expansion: Quasar Medical Acquires Two Strategic Facilities to Create Global CDMO Powerhouse - Stock Titan

Click here to get full coverage on HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak - Fierce Pharma

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak  Fierce Pharma

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak - Fierce Pharma

Click here to get full coverage on Exothera shutters; Lotte Biologics’ latest contract with an unnamed US client - Endpoints News

Exothera shutters; Lotte Biologics’ latest contract with an unnamed US client  Endpoints News

Exothera shutters; Lotte Biologics’ latest contract with an unnamed US client - Endpoints News

Click here to get full coverage on CDMO scale up: Resilience, Wheeler, SHL strengthen US ops - BioProcess International

CDMO scale up: Resilience, Wheeler, SHL strengthen US ops  BioProcess International

CDMO scale up: Resilience, Wheeler, SHL strengthen US ops - BioProcess International

Click here to get full coverage on mRNA Therapeutics CDMO Strategic Research 2025 | Market to - GlobeNewswire

mRNA Therapeutics CDMO Strategic Research 2025 | Market to  GlobeNewswire

mRNA Therapeutics CDMO Strategic Research 2025 | Market to - GlobeNewswire

Click here to get full coverage on Mabion launches €500,000 CDMO services contest at BIO - BioProcess International

Mabion launches €500,000 CDMO services contest at BIO  BioProcess International

Mabion launches €500,000 CDMO services contest at BIO - BioProcess International

Click here to get full coverage on Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe - Genetic Engineering and Biotechnology News

Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe  Genetic Engineering and Biotechnology News

Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe - Genetic Engineering and Biotechnology News

Click here to get full coverage on Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International

Zydus enters global biologics CDMO market with $75m facility acquisitions  BioProcess International

Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International

Click here to get full coverage on Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - PR Newswire

Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies  PR Newswire

Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - PR Newswire

Click here to get full coverage on Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research

Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034  Precedence Research

Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research

Click here to get full coverage on CDMO AmplifyBio closes doors amid tough market for early-stage cell and gene therapy development - Fierce Pharma

CDMO AmplifyBio closes doors amid tough market for early-stage cell and gene therapy development  Fierce Pharma

CDMO AmplifyBio closes doors amid tough market for early-stage cell and gene therapy development - Fierce Pharma

Click here to get full coverage on Biologics CDMO Market Surges with 15.7% CAGR, Set to Achieve US$ 84.9 Billion by 2034 - Market.us Media

Biologics CDMO Market Surges with 15.7% CAGR, Set to Achieve US$ 84.9 Billion by 2034  Market.us Media

Biologics CDMO Market Surges with 15.7% CAGR, Set to Achieve US$ 84.9 Billion by 2034 - Market.us Media

Click here to get full coverage on Lateral Flow Test Development and Contract Manufacturing | International - Abingdon Health

Lateral Flow Test Development and Contract Manufacturing | International  Abingdon Health

Lateral Flow Test Development and Contract Manufacturing | International - Abingdon Health

Click here to get full coverage on Biologics CDMO Market Size, Share | CAGR Of 15.7% - Market.us

Biologics CDMO Market Size, Share | CAGR Of 15.7%  Market.us

Biologics CDMO Market Size, Share | CAGR Of 15.7% - Market.us

Click here to get full coverage on Gene therapy CDMO Artis BioSolutions launches with acquisition of Landmark Bio - Fierce Pharma

Gene therapy CDMO Artis BioSolutions launches with acquisition of Landmark Bio  Fierce Pharma

Gene therapy CDMO Artis BioSolutions launches with acquisition of Landmark Bio - Fierce Pharma

Click here to get full coverage on mRNA Therapeutics CDMO Market Size to Hit USD 13.36 Billion by 2034 - Precedence Research

mRNA Therapeutics CDMO Market Size to Hit USD 13.36 Billion by 2034  Precedence Research

mRNA Therapeutics CDMO Market Size to Hit USD 13.36 Billion by 2034 - Precedence Research

Click here to get full coverage on U.S. Active Pharmaceutical Ingredients CDMO Market Report 2025-2030 | Competitive Analysis of Thermo Fisher Scientific, Novo Group, Cambrex, Piramal, Corden, Siegfried, Seqens, SK, Noramco, BSP - Yahoo Finance

U.S. Active Pharmaceutical Ingredients CDMO Market Report 2025-2030 | Competitive Analysis of Thermo Fisher Scientific, Novo Group, Cambrex, Piramal, Corden, Siegfried, Seqens, SK, Noramco, BSP  Yahoo Finance

U.S. Active Pharmaceutical Ingredients CDMO Market Report 2025-2030 | Competitive Analysis of Thermo Fisher Scientific, Novo Group, Cambrex, Piramal, Corden, Siegfried, Seqens, SK, Noramco, BSP - Yahoo Finance

Click here to get full coverage on CDMO Packaging Market Gains Momentum in Biologics & Personalized Medicine in 2025 - GlobeNewswire

CDMO Packaging Market Gains Momentum in Biologics & Personalized Medicine in 2025  GlobeNewswire

CDMO Packaging Market Gains Momentum in Biologics & Personalized Medicine in 2025 - GlobeNewswire

Click here to get full coverage on Meribel makes CDMO debut after series of acquisitions in Europe - Fierce Pharma

Meribel makes CDMO debut after series of acquisitions in Europe  Fierce Pharma

Meribel makes CDMO debut after series of acquisitions in Europe - Fierce Pharma

Click here to get full coverage on Pharmaceutical CDMO for Formulations Market Size to Hit USD 96.57 Billion by 2034 - Precedence Research

Pharmaceutical CDMO for Formulations Market Size to Hit USD 96.57 Billion by 2034  Precedence Research

Pharmaceutical CDMO for Formulations Market Size to Hit USD 96.57 Billion by 2034 - Precedence Research

Click here to get full coverage on PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea - Fierce Pharma

PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea  Fierce Pharma

PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea - Fierce Pharma

Click here to get full coverage on On the Rise: CDMO/CMO Expansions for Injectables - DCAT Value Chain Insights

On the Rise: CDMO/CMO Expansions for Injectables  DCAT Value Chain Insights

On the Rise: CDMO/CMO Expansions for Injectables - DCAT Value Chain Insights

Click here to get full coverage on U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034 - Yahoo Finance

U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034  Yahoo Finance

U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034 - Yahoo Finance

Click here to get full coverage on Five considerations when scaling up mAbs in partnership with a CDMO - Pharmaceutical Technology

Five considerations when scaling up mAbs in partnership with a CDMO  Pharmaceutical Technology

Five considerations when scaling up mAbs in partnership with a CDMO - Pharmaceutical Technology

Click here to get full coverage on CDMO insights podcast series: Our Experience is Your Strength | Episode #4 Commercial Launch - Clinical Trials Arena

CDMO insights podcast series: Our Experience is Your Strength | Episode #4 Commercial Launch  Clinical Trials Arena

CDMO insights podcast series: Our Experience is Your Strength | Episode #4 Commercial Launch - Clinical Trials Arena

Click here to get full coverage on LOTTE BIOLOGICS Accelerates Global CDMO Expansion with Dual Manufacturing Bases in North America and Asia, and Next-Generation ADC Modalities - BioSpace

LOTTE BIOLOGICS Accelerates Global CDMO Expansion with Dual Manufacturing Bases in North America and Asia, and Next-Generation ADC Modalities  BioSpace

LOTTE BIOLOGICS Accelerates Global CDMO Expansion with Dual Manufacturing Bases in North America and Asia, and Next-Generation ADC Modalities - BioSpace

Click here to get full coverage on Frost & Sullivan Released Report: "2025 China Pharmaceutical CDMO Industry Insight Blue Book" - Newsfile

Frost & Sullivan Released Report: "2025 China Pharmaceutical CDMO Industry Insight Blue Book"  Newsfile

Frost & Sullivan Released Report: "2025 China Pharmaceutical CDMO Industry Insight Blue Book" - Newsfile

Click here to get full coverage on PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea  Business Wire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire

Click here to get full coverage on U.S. Pharmaceutical CDMO Market Size to Hit USD 83.86 Billion by 2034 - BioSpace

U.S. Pharmaceutical CDMO Market Size to Hit USD 83.86 Billion by 2034  BioSpace

U.S. Pharmaceutical CDMO Market Size to Hit USD 83.86 Billion by 2034 - BioSpace

Click here to get full coverage on Evolving with purpose in the CDMO industry - worldfinance.com

Evolving with purpose in the CDMO industry  worldfinance.com

Evolving with purpose in the CDMO industry - worldfinance.com

Click here to get full coverage on Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes - Endpoints News

Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes  Endpoints News

Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes - Endpoints News

Click here to get full coverage on Radyus Research and Eurofins CDMO Alphora Announce Strategic Partnership to Accelerate and Optimize Drug Development - PR Newswire

Radyus Research and Eurofins CDMO Alphora Announce Strategic Partnership to Accelerate and Optimize Drug Development  PR Newswire

Avid Bioservices Inc (CDMO)

Price Chart

Key Statistics

Technicals

About CDMO

Latest News

Permira looks to launch $4B sale of CDMO Cambrex: FT - Fierce Pharma

Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium - Korea JoongAng Daily

Matica Biotechnology inks AAV vector CDMO deal with Cirsium Biosciences - koreabiomed.com

Advanced Charts

Top Gainers

Top Losers